<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00886431</url>
  </required_header>
  <id_info>
    <org_study_id>Vitrification study</org_study_id>
    <secondary_id>CCMO NL23499.000.08</secondary_id>
    <secondary_id>METC 08/183</secondary_id>
    <nct_id>NCT00886431</nct_id>
  </id_info>
  <brief_title>Vitrification Versus Slow Cooling of Human Cleavage Stage Embryos</brief_title>
  <official_title>A Double Blinded, Randomised Controlled Trial Comparing the Effectiveness of Vitrification to Slow Cooling in Cryopreserving Human Preimplantation Embryos</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vrije Universiteit Brussel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>UMC Utrecht</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human embryos can be preserved for later transfers by freezing. Traditionally the slow
      cooling method has been used. About 70% of the embryos remain fully intact after thawing.
      However, the remaining 30% of the embryos become (partially) damaged, and this freezing
      damage reduces their chance to implant. Recently an ultra rapid freezing method, called
      vitrification has been developed. During vitrification no damaging ice crystals are formed
      and the embryo freezes in a glass like state.

      It appears that the freezing damage is reduced when embryos are vitrified. Observational
      studies in humans indicate that embryos are successfully preserved by vitrification, as
      indicated by promising pregnancy rates following thawing. However, the effectiveness of
      vitrification in relation to slow cooling with respect to pregnancy rates has so far not been
      evaluated by a randomised, controlled trial. The aim of this study is to investigate whether
      vitrification significantly improves embryo survival and ongoing pregnancy rates when
      compared to embryos frozen by slow cooling.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      time of allocation: following embryo selection

      type of embryos: cleavage stage -, morula stage or early blastocyst stage embryo (day3 - day4
      after oocyte collection)

      cryoprotectants: sucrose, dimethylsulfoxide, ethyleneglycol

      vitrification storage device: high security vitrification straws
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>May 2009</start_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percent change of the ongoing pregnancy rate per patient/couple who use their thawed embryos (following a fesh embryo transfer which did not result in an ongoing pregnancy) from baseline (slow cooling) to end point (vitrification).</measure>
    <time_frame>ongoing pregnancy is established 10 weeks following the transfer of a frozen embryo</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>post-thaw embryo survival rate</measure>
    <time_frame>1 hour after thawing</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ongoing pregnancy rate per patient using their thawed embryos (independent of whether they became pregnant following a fresh embryo transfer or not</measure>
    <time_frame>10 weeks following transfer of frozen thawed embryo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>implantation rate per thawed embryo</measure>
    <time_frame>10 weeks after transfer of thawed embryo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>implantation rate per transferred thawed embryo</measure>
    <time_frame>10 weeks after transfer of thawed embryo</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cumulative implantation rate per cryopreservation</measure>
    <time_frame>10 weeks after thawed embryo transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ongoing pregnancy rate per frozen-thaw cycle</measure>
    <time_frame>10 weeks following thawed embryo transfer</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>average number of frozen-thawed cycles per patient</measure>
    <time_frame>is variable</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>post thaw development (categorial) per thawed embryo</measure>
    <time_frame>24 hours following thawing</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>average number of cryo-thaw cycles to ongoing pregnancy</measure>
    <time_frame>variable, up to 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>average number of thawed embryos to ongoing implantation</measure>
    <time_frame>variable, up to 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life birth rate</measure>
    <time_frame>9 month after pregnancy test</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">146</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Vitrification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The embryos of patients allocated to this arm will be cryopreserved by vitrification.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Slow cooling</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The embryos of patients allocated to this arm will be cryopreserved by the slow cooling method, which is the standard method (=no intervention)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>embryo vitrification</intervention_name>
    <description>Ultra rapid cooling of embryos by immersion in liquid nitrogen. The formation of potentially damaging ice crystals is prevented by briefly incubating the embryos in high concentrations of a mix of cryoprotectants.</description>
    <arm_group_label>Vitrification</arm_group_label>
    <other_name>vitrification</other_name>
    <other_name>high security vitrification straws</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female patient age 35 years or less

          -  embryos are obtained by in vitro fertilization (IVF) or intra cytoplasmatic
             spermatozoon injection (ICSI)

          -  single embryo transfer

          -  1rst IVF/ICSI treatment with an embryo transfer

          -  availability of cryopreservable embryos

        Exclusion Criteria:

          -  female patient age is 36 years or older

          -  participants of oocyte donation program

          -  participants of percutaneous spermatozoon aspiration (PESA) program

          -  couples with a finite source of spermatozoa

          -  absence of cryopreservable embryos
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bart C Fauser, Prof.,MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Academic Hospital of Brussels</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center of Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Boonkusol D, Gal AB, Bodo S, Gorhony B, Kitiyanant Y, Dinnyes A. Gene expression profiles and in vitro development following vitrification of pronuclear and 8-cell stage mouse embryos. Mol Reprod Dev. 2006 Jun;73(6):700-8.</citation>
    <PMID>16541460</PMID>
  </reference>
  <reference>
    <citation>Burns WN, Gaudet TW, Martin MB, Leal YR, Schoen H, Eddy CA, Schenken RS. Survival of cryopreservation and thawing with all blastomeres intact identifies multicell embryos with superior frozen embryo transfer outcome. Fertil Steril. 1999 Sep;72(3):527-32.</citation>
    <PMID>10519629</PMID>
  </reference>
  <reference>
    <citation>Desai N, Blackmon H, Szeptycki J, Goldfarb J. Cryoloop vitrification of human day 3 cleavage-stage embryos: post-vitrification development, pregnancy outcomes and live births. Reprod Biomed Online. 2007 Feb;14(2):208-13.</citation>
    <PMID>17298725</PMID>
  </reference>
  <reference>
    <citation>Edgar DH, Bourne H, Speirs AL, McBain JC. A quantitative analysis of the impact of cryopreservation on the implantation potential of human early cleavage stage embryos. Hum Reprod. 2000 Jan;15(1):175-9.</citation>
    <PMID>10611209</PMID>
  </reference>
  <reference>
    <citation>Kasai M, Mukaida T. Cryopreservation of animal and human embryos by vitrification. Reprod Biomed Online. 2004 Aug;9(2):164-70. Review.</citation>
    <PMID>15333245</PMID>
  </reference>
  <reference>
    <citation>Mukaida T, Nakamura S, Tomiyama T, Wada S, Kasai M, Takahashi K. Successful birth after transfer of vitrified human blastocysts with use of a cryoloop containerless technique. Fertil Steril. 2001 Sep;76(3):618-20.</citation>
    <PMID>11532492</PMID>
  </reference>
  <reference>
    <citation>Rama Raju GA, Haranath GB, Krishna KM, Prakash GJ, Madan K. Vitrification of human 8-cell embryos, a modified protocol for better pregnancy rates. Reprod Biomed Online. 2005 Oct;11(4):434-7.</citation>
    <PMID>16274602</PMID>
  </reference>
  <reference>
    <citation>Salumets A, Suikkari AM, Mäkinen S, Karro H, Roos A, Tuuri T. Frozen embryo transfers: implications of clinical and embryological factors on the pregnancy outcome. Hum Reprod. 2006 Sep;21(9):2368-74. Epub 2006 May 9.</citation>
    <PMID>16684837</PMID>
  </reference>
  <reference>
    <citation>Sheehan CB, Lane M, Gardner DK. The CryoLoop facilitates re-vitrification of embryos at four successive stages of development without impairing embryo growth. Hum Reprod. 2006 Nov;21(11):2978-84. Epub 2006 Sep 1.</citation>
    <PMID>16950825</PMID>
  </reference>
  <reference>
    <citation>Stehlik E, Stehlik J, Katayama KP, Kuwayama M, Jambor V, Brohammer R, Kato O. Vitrification demonstrates significant improvement versus slow freezing of human blastocysts. Reprod Biomed Online. 2005 Jul;11(1):53-7.</citation>
    <PMID>16102287</PMID>
  </reference>
  <reference>
    <citation>Takahashi K, Mukaida T, Goto T, Oka C. Perinatal outcome of blastocyst transfer with vitrification using cryoloop: a 4-year follow-up study. Fertil Steril. 2005 Jul;84(1):88-92.</citation>
    <PMID>16009162</PMID>
  </reference>
  <reference>
    <citation>Al-Hasani S, Ozmen B, Koutlaki N, Schoepper B, Diedrich K, Schultze-Mosgau A. Three years of routine vitrification of human zygotes: is it still fair to advocate slow-rate freezing? Reprod Biomed Online. 2007 Mar;14(3):288-93.</citation>
    <PMID>17359578</PMID>
  </reference>
  <reference>
    <citation>Liebermann J, Tucker MJ. Comparison of vitrification and conventional cryopreservation of day 5 and day 6 blastocysts during clinical application. Fertil Steril. 2006 Jul;86(1):20-6. Epub 2006 Jun 8.</citation>
    <PMID>16762345</PMID>
  </reference>
  <reference>
    <citation>Yokota Y, Sato S, Yokota M, Yokota H, Araki Y. Birth of a healthy baby following vitrification of human blastocysts. Fertil Steril. 2001 May;75(5):1027-9.</citation>
    <PMID>11334922</PMID>
  </reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2009</study_first_submitted>
  <study_first_submitted_qc>April 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2009</study_first_posted>
  <last_update_submitted>November 26, 2014</last_update_submitted>
  <last_update_submitted_qc>November 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UMC Utrecht</investigator_affiliation>
    <investigator_full_name>Bart CJM Fauser</investigator_full_name>
    <investigator_title>Prof. dr. B Fauser</investigator_title>
  </responsible_party>
  <keyword>IVF</keyword>
  <keyword>embryo cryopreservation</keyword>
  <keyword>vitrification</keyword>
  <keyword>slow cooling</keyword>
  <keyword>slow freezing</keyword>
  <keyword>surplus embryos</keyword>
  <keyword>Human Reproduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

